Author Archives: Editor

Aluminum Adjuvants in Vaccines: Testing a substitute adjuvant with new HepB shot

Leave a reply

In February 2018, the FDA and CDC approved the recommendation for a new hepatitis B vaccine, Heplisav-B targeting adults over the age of 18. The U.S. Food and Drug Administration (FDA) had twice rejected the application for licensure for Heplisav-B in the past four years because of safety signals. Heplisav-B differs from other licensed hepatitis B vaccines in that it contains a new synthetic adjuvant known as cytosine phosphoguanine 1018 (CpG 1018) composed of short synthetic DNA molecules. In 2016, the FDA rejected an application for licensure for the Heplisav-B vaccine, because the agency was concerned about an increased rate of heart attacks and deaths in people who had been given the vaccine. During the trial, approximately 14 subjects had heart attacks. In July 2017, the FDA committee convened to re-evaluate the scientific evidence and make a decision on whether Heplisav B should or should not be approved for use in the U.S. This committee had only one cardiologist on the team, Milton Packer, MD, who is a distinguished scholar in cardiovascular science at the Baylor University Medical Center in Dallas, Texas. According to Dr. Packer, it was possible that the Heplisav B vaccine’s novel adjuvant was related to the higher number of heart attacks in study participants who received the experimental vaccine. He stated: “To know if the 7 -1 heart attack imbalance represented a real risk, we’d need comparative data in 50,000 people.” However, the only way to conduct such a large trial would be to approve the vaccine and see what happens in the public. With Dr. Packer abstaining in his vote to recommend the vaccine, the FDA committee approved it anyway. Dr. Packer stated: “Why did I abstain? Based on the available data, it was impossible for anyone to know if the increase in heart attack risk was real. There is a simple rule in life: if you don’t know, you should say you don’t know.” The vaccine is now available to the public, and all those who receive it are basically guinea pigs to find out if heart attacks will result from the experimental vaccine, and if it will continue to have FDA approval.

Read more…

[Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].

Study on combining Aluminum with 1018   (CPG1018 as above)

Study: Cytochrome P450 1A1 and 1B1 promoter CpG island methylation regulates rat liver injury induced by isoniazid

Brazil Judge suspends use of Glyphosate

Leave a reply

A Brazilian judge has suspended the use of products containing the agrochemical glyphosate, a widely employed herbicide for soy and other crops in the country, according to legal filings.

A federal judge in Brasilia ruled that new products containing the chemical could not be registered in the country and existing registrations would be suspended within the next 30 days, until the government reevaluates their toxicology.

The decision, which could be subject to multiple appeals, also applies to the insecticide abamectin and the fungicide thiram.

The ruling affects companies such as Monsanto Co, which markets a glyphosate-resistant, genetically-modified type of soybean that is planted on a large scale in Brazil. Monsanto is now a unit of Bayer AG, following a $62.5 billion takeover of the U.S. seed major which closed in June.

READ More..

HPV (Gardasil) Cochrane BOGUS STUDY details

Leave a reply

What happened to Cochrane?

Cochrane, a non-profit organization whose research helps individuals make informed health decisions, published a review in May 2018 claiming that the HPV vaccine helps prevent cancer and precancerous changes in the cervix with no serious side effects. The review aimed to increase public confidence in the HPV vaccine – both its efficacy in cancer prevention and its long-term safety. This publication has the potential to affect the opinions of many people regarding the HPV vaccine, possibly reassuring some parents and convincing them to choose it
for their children. READ ARTICLE

VLA Comment: The article is interesting to read however, the link to the BMJ review of the HPV Cochrane study shows the poor and fallacious design of the study whose conclusion is that the HPV vaccine is safe.  The Cochrane HPV vaccine review was incomplete and ignored important evidence of bias

Pfizer Vice President blows the whistle on ‘deadly’ vaccines.

Leave a reply

Pfizer Vice President Dr. Peter Rost blows the whistle on ‘deadly’ vaccines.

The former vice president of the world’s largest pharmaceutical company has blown the whistle to expose the true dangers of mandatory vaccinations. Dr. Peter Rost lifted the lid on vaccines and revealed that the Gardasil inoculation, in particular, is in fact, “deadly”. In a shocking exposé from one of the highest-ranking whistleblowers to date, Rost has also claimed that Big Pharma is purposely keeping the public unhealthy so they can make a fortune from continual treatments of illnesses rather than curing them. Dr. Rost made the revelations during an interview for the “One More Girl” documentary in which he candidly discussed how the main objective for vaccines and pharmaceutical drugs is to keep the public in a constant state of disease.
READ MORE…

Pilot Study: Non-invasive therapy eliminates Aluminum from Alzheimer patients

Leave a reply

Non-invasive therapy to reduce the body
burden of aluminium in Alzheimer’s disease

Abstract. There are unexplained links between human exposure to aluminium and the incidence, progression and aetiology of Alzheimer’s disease. The null hypothesis which underlies any link is that there would be no Alzheimer’s disease in the effective absence of a body burden of aluminium. To test this the latter would have to be reduced to and retained at a level that was commensurate with an Alzheimer’s disease-free population. In the absence of recent human interference in the biogeochemical cycle of aluminium the reaction of silicic acid with aluminium has acted as a geochemical control of the biological availability of aluminium. This same mechanism might now be applied to both the removal of aluminium from the body and the reduced entry of aluminium into the body while ensuring that essential metals, such as iron, are unaffected. Based upon the premisethat urinary aluminium is the best non-invasive estimate of  body burden of aluminium patients with Alzheimer’s disease were asked to drink 1.5 L of a silicic acid-rich mineral water each day for five days and, by comparison of their urinary excretion of aluminium pre-and post this simple procedure, the influence upon their body burden of aluminium was determined. Drinking the mineral water increased significantly (P <0.001) their urinary excretion of silicic acid (34.3 ± 15.2 to 55.7 ± 14.2 μmol/mmol
creatinine) and concomitantly reduced significantly (P = 0.037) their urinary excretion of aluminium (86.0 ± 24.3 to 62.2 ± 23.2 nmol/mmol creatinine). The latter was achieved without any significant (P >0.05) influence upon the urinary excretion of iron (20.7 ± 9.5 to 21.7 ± 13.8 nmol/mmol creatinine). The reduction in urinary aluminium supported the future longer-term
use of silicic acid as non-invasive therapy for reducing the body burden of aluminium in Alzheimer’s disease.

Click here for Pilot Study

101 Million dollars paid to child victim of MMR vacine

Leave a reply

$101 Million Dollar Vaccine Injury Award for Encephalopathy from MMR Vaccine

(July 17th, 2018 – SARASOTA, FL) — Attorneys at Maglio Christopher & Toale, P.A. negotiated a $101 million dollar settlement for an infant who suffered a severe reaction to the Measles Mumps Rubella (MMR) vaccine.

O.R.* was a one-year-old healthy baby girl who was already walking and climbing.  On February 13, 2013, she received vaccinations for Measles Mumps Rubella (MMR), Hepatitis A, Haemophilus Influenzae type B (Hib), Prevnar (pneumonia), and Varicella (chickenpox).  That evening, the mother noticed baby O.R. was irritable and feverish. After a call to the pediatrician, the doctor advised Mom to give her Tylenol and Benadryl. The fever continued for several days and on the evening before the baby’s scheduled pediatrician visit, O.R. began having severe seizures. She was rushed to the emergency room.  Baby O.R. went into cardiac and respiratory arrest and doctors placed her on a ventilator.

The seizures and cardiac arrest left O.R. with a severe brain injury, encephalopathy, cortical vision impairment, truncal hypotonia (low muscle tone), and kidney failure. After months of treatment at the hospital, baby O.R. finally went home, but her disabilities require specialized medical care and supervision around the clock for the rest of her life.  READ MORE…

 

 

Vaccine Court:(New) Attorney Fees-may not be paid if vaccine injury case is lost

Leave a reply

Good Faith and a Reasonable Basis

The answer to the third question to compensate attorneys, even when their clients were not compensated by the NVICP, is a devilish debate and where the special masters try to hold a hammer over the attorneys.

I wonder how many times the following statement has been whispered or inferred within the discussion of attorney fees, “You must play ball, or we will not compensate you for your work now and possibly in the future?” The statute allows for payment, yet the devil is in the details.

Within the NVICP, attorneys shall be compensated for fees and expenses when a client is successful with their petition for compensation from an injury or death. [6]

When a petitioner is not successful, the Special Masters can award attorney fees and expenses at their discretion. [7]

And this is where it gets very tricky, and recently, this is where we start to lose our ability to obtain legal counsel to represent our claims within the NVICP.

The Special Master uses his/her discretion to award fees using the Good Faith and Reasonable Basis standard.

Even if a petitioner is not awarded “compensation,” the special master “may award an amount of compensation to cover petitioner’s reasonable attorneys’ fees . . . if the special master or court determines that the petition was brought in good faith and there was a reasonable basis for the claim for which the petition was brought.”[8]  READ MORE…

Foods and Medications to Avoid with MAOIs

Leave a reply

Some specific pharmaceutical drugs that should not be combined with MAOIs (some are mild risks, others serious):

– Actifed
– Adderall
– Alaproclate
– Albuterol (Proventil, Ventolin)
– Amantadine hydrochloride (Symmetrel)
– Amiflamine
– Amineptine
– Amitriptaline
– Amoxapine (Asendin)
– Atomoxedine
– Bazinaprine
– Befloxetone’
– Befol
– Benadryl
– Benmoxinb (Nerusil, Neuralex)
– Benylin
– Benzedrine
– Benzphetamine (Didrex)
– Bicifadine
– Brasofensine
– Brofaromine (Consonar)
– Buprenorphine
– Bupropion (Wellbutrin)
– Buspirone (BuSpar)
– Butriptyline
– Carbamazepine (Tegretol, Epitol)
– Chlorpheniramine
– Chlor-Trimeton
– Cimoxetone
– Citalopram (Celexa)
– Clomipramine (Anafranil)
– Clorgyline
– Codeine
– Cyclobenzaprine (Flexeril)
– Cyclizine (Marezine)
– D-deprenyl
– Dapoxotine
– Desipramine (Pertofrane, Norpramin)
– Desvenlafaxine
– Dextroamphetamine (Dexedrine)
– Dextromethorphan (DXM)
– Dibenzepin
– Dienolide kavapyrone desmethoxyyangonin
– Diethylpropion
– Disopyramide (Norpace)
– Disulfiram (Antabuse)
– Dobutamine
– Dopamine (Intropin)
– Dosulepin
– Doxepin (Sinequan)
– Duloxetine (Cymbalta)
– Emsam
– Entacapone
– Ephedrine
– Epinephrine (Adrenalin)
– Escitalopram (Lexapro)
– Esuprone
– Etorphine
– Femoxitine
– Fenfluramine (Pondimin)
– Flavoxate Hydrochloride (Urispas)
– Fluoxetine (Prozac)
– Fluvoxamine
– Furazolidone (Furoxone)
– Gabapentin
– Guanethedine
– Guanadrel (Hylorel)
– Guanethidine (Ismelin)
– Hydralazine (Apresoline)
– Hydrazine
– 5-Hydroxytryptophan
– Imipramine (Tofranil)
– Iprindole
– Iproniazid (Marsilid, Iprozid, Ipronid, Rivivol, Propilniazida)
– Iproclozide (Sursum)
– Isocarboxazid (Marplan)
– Isoniazid (Laniazid, Nydrazid)
– Isoniazid rifampin (Rifamate, Rimactane)
– Isoproterenol (Isuprel)
– L-dopa (Sinemet)
– Ladostigil
– Lazabemide (Pakio, Tempium)
– Levodopa (Dopar, Larodopa)
– Linezolid (Zyvox, Zyvoxid)
– Lithium (Eskalith)
– Lofepramine
– Loratadine (Claritin)
– Maprotiline (Ludiomil)
– Mebanazine (Actomol)
– Medifoxamine
– Melitracen
– Meperidine (Demerol)
– Metaproterenol (Alupent, Metaprel)
– Metaraminol (Aramine)
– Metfendrazine (Inkazan)
– Methamphetamine (Desoxyn)
– Methyldopa (Aidomet)
– Methylphenidate (Ritalin)
– Metralindole
– Mianserin
– Milacimide
– Milnacipran
– Minaprine (Cantor)
– Mirtazapine (Remeron)
– Mofegeline
– Moclobemide (Aurorix, Manerix)
– Monomethylhydrazine
– Montelukast (Singulair)
– Nalbufrine
– Naloxone
– Naltrexone
– Nefazodone
– Nialamide (Niamid)
– Nisoxetine
– Nomifensine
– Norepinephrine (Levophed)
– Nortriptyline (Aventyl)
– Octamoxin (Ximaol, Nimaol)
– Oxybutynin chloride (Ditropan)
– Oxycodone
– Oxymetazoline (Afrin, Dimetapp)
– Oxymorphone
– Orphenadrine (Norflex)
– Pargyline (Eutonyl)
– Parnate
– Paroxetine (Paxil)
– Pemoline (Cylert)
– Percocet
– Pethedine (Demerol)
– Phendimetrazine (Plegiline)
– Phenelzine (Nardil)
– Phenergen
– Phenelzine (Nardil, Nardelzine)
– Pheniprazine (Catron)
– Phenmetrazine
– Phenoxypropazine (Drazine)
– Phentermine
– Phenylephrine (Dimetane, Dristan decongestant, Neo-Synephrine)
– Phenylhydrazine
– Phenylpropanolamine (found in many cold medicines)
– Phenelzine (Nardil)
– Pirlindole (Pirazidol)
– Procarbazine (Matulane)
– Procainamide (Pronestyl)
– Protriptyline (Vivactil)
– Pseudoephedrine
– Oxymetazoline (Afrin)
– Quinidine (Quinidex)
– Rasagiline (Azilect)
– Reboxetine
– Reserpine (Serpasil)
– Risperidone
– Salbutemol
– Salmeterol
– Selegiline (Eldepryl, Emsam, Zelapar)
– Sercloramine
– Sertraline (Zoloft)
– Sibutramine
– Sumatriptan (Imitrex)
– Terfenadine (Seldane-D)
– Tegretol
– Temaril
– Tesofensine
– Tetrindole
– Theophylline (Theo-Dur)
– Thesbutiaint
– Thioridazine (Mellaril)
– Tianeptine
– Tolcapone
– Toloxatone (Humoryl)
– Tramadol
– Tranylcypromine (Parnate)
– Trazodone
– Tricyclic antidepressants (Amitriptyline, Elavil)
– Trimipramine (Surmontil)
– Triptans
– Tyrima
– Vanoxerine
– Venlafaxine (Effexor)
– Viloxezine
– Yohimbine
– Zimelidine
– Ziprasidone (Geodon)

READ MORE…